Bernard Campos Araruna Giancristoforo

Bernard Campos Araruna Giancristoforo

Auto-generated profile, based on publicly available information

Bernard Campos Araruna Giancristoforo

Rede D'Or São Luiz, Rio de Janeiro, Brazil; Partner, Rivoa Interventional Radiology Group, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2025 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
RMRafaela Correia Maciel
Rafaela Correia Maciel
WLWei Jun Lee
Wei Jun Lee
BMBeatriz Aguiar de Macedo
Beatriz Aguiar de Macedo
DSDavi Barbosa Pereira da Silva
Davi Barbosa Pereira da Silva
ABAmanda Boutrik
Amanda Boutrik
BCBernard Giancristoforo Campos
Bernard Giancristoforo Campos

1 April 2026 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
GSGustavo Regus Schuster
Gustavo Regus Schuster
RMRafaela Correia Maciel
Rafaela Correia Maciel
MMMaria Clara Merighi
Maria Clara Merighi
CSCláudia Figueredo Nascimento Salomã Santos
Cláudia Figueredo Nascimento Salomã Santos
GLGabriela Gracioli de Lima
Gabriela Gracioli de Lima
BGBernard Campos Araruna Giancristoforo
Bernard Campos Araruna Giancristoforo

16 May 2025 in CardioVascular and Interventional Radiology
Verified
Journal Article
Closed access
PDF file
JMJoaquim Mauricio Motta-Leal-Filho
Joaquim Mauricio Motta-Leal-Filho
RBRaphael Levigard Braz
Raphael Levigard Braz
HSHenrique Serrão
Henrique Serrão
BCBernard Giancristoforo Campos
Bernard Giancristoforo Campos
FSFlavio Scavone Stefanini
Flavio Scavone Stefanini
TNThiago Franchi Nunes
Thiago Franchi Nunes

16 May 2026 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Open access
BGBernard Campos Araruna Giancristoforo
Bernard Campos Araruna Giancristoforo
DSDavi Barbosa Pereira da Silva
Davi Barbosa Pereira da Silva
MMMaria Clara Merighi
Maria Clara Merighi
RMRafaela Correia Maciel
Rafaela Correia Maciel
RLRaphael Braz Levigard
Raphael Braz Levigard
JLJose Hugo Mendes Luz
Jose Hugo Mendes Luz
To evaluate the efficacy of tract embolization in preventing pneumothorax and chest tube placement after CT-guided percutaneous lung biopsy. PubMed, Embase, Web of Science, and Cochrane Library were searched through March 2025 for studies comparing tract embolization versus no embolization. RR with 95% CI were pooled using random-effects models. ARR and NNT were calculated using the Control Event Rate (CER). Subgroup analyses were performed by embolic agent, study design, and chest tube placement criteria. Certainty of evidence was assessed using the GRADE approach. All analyses were conducted in R. A total of 26 studies comprising 10,689 patients were included, of whom 5,066 underwent TE. TE was associated with a lower risk of pneumothorax (RR 0.59; 95% CI 0.53-0.65; p<0.001; I2=33%), with blood patch (RR 0.62; 95% CI 0.51-0.76; I2=48.9%) and gelfoam (RR 0.56; 95% CI 0.47-0.66; I2=31.8%). TE also reduced chest tube placement (RR 0.47; 95% CI 0.37-0.58; p<0.001; I2=32.9%), with blood patch (RR 0.47; 95% CI 0.33-0.67; I2=30%) and gelfoam (RR 0.48; 95% CI 0.31-0.73; I2=42.3%). Tract embolization after CT-guided percutaneous lung biopsy was associated with reduced pneumothorax and chest tube placement rates, with consistent reductions across blood patch, gelatin-based agents, and hydrogel. These findings support tract embolization as an effective adjunct to reduce procedure-related complications.